Prevalence, incidence and risk factors for acquisition and colonization of extended-spectrum beta-lactamase- and carbapenemase-producing Enterobacteriaceae from dogs attended at a veterinary hospital in Spain

Comp Immunol Microbiol Infect Dis. 2023 Jan:92:101922. doi: 10.1016/j.cimid.2022.101922. Epub 2022 Nov 29.

Abstract

The last 10 years have seen a progressive increase in antibiotic resistance rates in bacteria isolated from companion animals. Exposure of individuals to resistant bacteria from companion animals, such as extended-spectrum beta-lactamase- (ESBL) and carbapenemase- (CPE) producing Enterobacteriaceae, can be propitiated. Few studies evaluate the incidence and risk factors associated with colonization by multidrug-resistant bacteria in dogs. This work aims to estimate the prevalence, incidence and risk factors associated with colonization of ESBL-E and CPE-E in 44 canine patients hospitalized in a veterinary hospital. The antimicrobial susceptibility of Enterobacteriaceae strains was analyzed and the molecular detection of resistant genes was performed. A prevalence of 25.0% and an incidence of ESBL-E of 45.5% were observed in dogs colonized by Enterobacteriaceae at hospital admission and release, respectively. Escherichia coli, Klebsiella pneumoniae, Citrobacter koseri and Morganella morganii were identified as ESBL-producing bacterial species. Resistance genes were detected for ESBL-producing strains. No CPE isolates were obtained on the CPE-selective medium. The administration of corticosteroids prior to hospitalization and the presence of concomitant diseases were associated with colonization by these bacteria in dogs. Considering that one-quarter of the patients evaluated were colonized by ESBL-E, companion animals should be considered as potential transmission vehicles and ESBL-E reservoirs for humans. Special care should be taken in animals attended at veterinary hospitals, as the length of stay in the hospital could increase the risks.

Keywords: Beta-lactamase; Carbapenemase; Dogs; Enterobacteriaceae; Risk factors; Veterinary hospital.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Carbapenem-Resistant Enterobacteriaceae*
  • Dog Diseases* / epidemiology
  • Dog Diseases* / microbiology
  • Dogs
  • Enterobacteriaceae / genetics
  • Enterobacteriaceae Infections* / diagnosis
  • Enterobacteriaceae Infections* / epidemiology
  • Enterobacteriaceae Infections* / veterinary
  • Escherichia coli
  • Hospitals, Animal
  • Humans
  • Incidence
  • Prevalence
  • Risk Factors
  • Spain / epidemiology
  • beta-Lactamases / genetics

Substances

  • beta-Lactamases
  • Anti-Bacterial Agents